Macrophage Migration Inhibitory Factor and Gene Polymorphism (rs755622G>C) in Unstable Vitiligo Patients
Open Access
- 1 January 2023
- journal article
- research article
- Published by Wiley in Dermatologic Therapy
- Vol. 2023 (1)
Abstract
Vitiligo pathogenesis is related to the macrophage migration inhibitory factor (MIF) protein. This study aimed to assess the lesional MIF levels and gene polymorphisms (rs755622G>C) in patients with vitiligo. To assess the consequences of combining narrow‐band ultraviolet B with oral minipulse prednisolone as opposed to a combination with oral methotrexate on MIF levels in vitiligo patients, 50 unstable vitiligo patients and 50 controls were randomly chosen for comparison. MIF levels in skin homogenates and MIF (rs755622G>C) single nucleotide polymorphisms were assessed using the ELISA and the polymerase chain reaction restriction fragment length polymorphism (RFLP‐PCR) techniques. We found significantly higher lesional MIF levels, a higher frequency of both (GC) and (CC) genotypes, and a significantly more frequent mutant allele (C) in patients than in controls. In addition, there was a significantly lower frequency of the allele (C) among patients who exhibited moderate to marked therapeutic improvement than among those who showed minimal to mild improvement. In conclusion, tissue MIF and gene polymorphisms were associated with vitiligo. In addition, oral corticosteroids, narrow‐band ultraviolet B, methotrexate‐targeted tissue MIF, and gene polymorphisms can improve unstable vitiligo.Keywords
This publication has 26 references indexed in Scilit:
- Macrophage migration inhibitory factor: Association of −794 CATT5–8 and −173 G>C polymorphisms with TNF-α in systemic lupus erythematosusHuman Immunology, 2014
- Macrophage Migration Inhibitory Factor: A Multifunctional Cytokine in Rheumatic DiseasesArthritis, 2010
- Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of diseaseClinical and Experimental Dermatology, 2009
- Up-regulated macrophage migration inhibitory factor protects apoptosis of dermal fibroblasts in patients with systemic sclerosisClinical and Experimental Immunology, 2008
- Macrophage migration inhibitory factor (MIF) in bullous pemphigoidJournal of Dermatological Science, 2008
- An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad / narrow band UVB phototherapy in progressive vitiligoIndian Journal of Dermatology, Venereology and Leprology, 2008
- A Clarification of the Hardy–Weinberg LawGenetics, 2006
- Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factorArthritis & Rheumatism, 2005
- Role of macrophage migration inhibitory factor (MIF) in the skinJournal of Dermatological Science, 2005
- Expression of macrophage migration inhibitory factor in diffuse systemic sclerosisAnnals of the Rheumatic Diseases, 2003